TrialFrontiers in immunology2025

Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation - 5 year results of a prospective pilot study.

Rolf Weimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.